Shanghai Pharmaceuticals Holding Co., Ltd (HKG:2607)

HKG:2607 Statistics

Total Valuation

HKG:2607 has a market cap or net worth of HKD 66.48 billion. The enterprise value is 96.41 billion.

Market Cap	66.48B
Enterprise Value	96.41B

Important Dates

The last earnings date was Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	Jul 16, 2025

Share Statistics

Current Share Class	919.07M
Shares Outstanding	n/a
Shares Change (YoY)	+0.09%
Shares Change (QoQ)	+0.29%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.58B

Valuation Ratios

The trailing PE ratio is 10.00 and the forward PE ratio is 10.98.

PE Ratio	10.00
Forward PE	10.98
PS Ratio	0.22
PB Ratio	0.68
P/TBV Ratio	1.14
P/FCF Ratio	14.55
P/OCF Ratio	9.63
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.30, with an EV/FCF ratio of 21.10.

EV / Earnings	14.50
EV / Sales	0.32
EV / EBITDA	8.30
EV / EBIT	10.68
EV / FCF	21.10

Financial Position

The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.69.

Current Ratio	1.32
Quick Ratio	0.99
Debt / Equity	0.69
Debt / EBITDA	5.75
Debt / FCF	14.68
Interest Coverage	4.53

Financial Efficiency

Return on equity (ROE) is 8.50% and return on invested capital (ROIC) is 3.57%.

Return on Equity (ROE)	8.50%
Return on Assets (ROA)	2.25%
Return on Invested Capital (ROIC)	3.57%
Return on Capital Employed (ROCE)	8.44%
Revenue Per Employee	6.07M
Profits Per Employee	132,698
Employee Count	49,402
Asset Turnover	1.21
Inventory Turnover	6.52

Taxes

In the past 12 months, HKG:2607 has paid 3.01 billion in taxes.

Income Tax	3.01B
Effective Tax Rate	27.46%

Stock Price Statistics

The stock price has increased by +18.97% in the last 52 weeks. The beta is 0.38, so HKG:2607's price volatility has been lower than the market average.

Beta (5Y)	0.38
52-Week Price Change	+18.97%
50-Day Moving Average	12.44
200-Day Moving Average	12.03
Relative Strength Index (RSI)	46.46
Average Volume (20 Days)	3,622,378

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2607 had revenue of HKD 304.00 billion and earned 6.65 billion in profits. Earnings per share was 1.79.

Revenue	304.00B
Gross Profit	32.11B
Operating Income	9.06B
Pretax Income	10.98B
Net Income	6.65B
EBITDA	10.88B
EBIT	9.06B
Earnings Per Share (EPS)	1.79

Balance Sheet

The company has 52.10 billion in cash and 67.04 billion in debt, giving a net cash position of -14.94 billion.

Cash & Cash Equivalents	52.10B
Total Debt	67.04B
Net Cash	-14.94B
Net Cash Per Share	n/a
Equity (Book Value)	97.37B
Book Value Per Share	22.19
Working Capital	48.57B

Cash Flow

In the last 12 months, operating cash flow was 6.90 billion and capital expenditures -2.34 billion, giving a free cash flow of 4.57 billion.

Operating Cash Flow	6.90B
Capital Expenditures	-2.34B
Free Cash Flow	4.57B
FCF Per Share	n/a

Margins

Gross margin is 10.56%, with operating and profit margins of 2.98% and 2.19%.

Gross Margin	10.56%
Operating Margin	2.98%
Pretax Margin	3.61%
Profit Margin	2.19%
EBITDA Margin	3.58%
EBIT Margin	2.98%
FCF Margin	1.50%

Dividends & Yields

This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 2.60%.

Dividend Per Share	0.32
Dividend Yield	2.60%
Dividend Growth (YoY)	-39.97%
Years of Dividend Growth	n/a
Payout Ratio	57.86%
Buyback Yield	-0.09%
Shareholder Yield	2.51%
Earnings Yield	10.00%
FCF Yield	6.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2607 has an Altman Z-Score of 2.01 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.01
Piotroski F-Score	5